Novartis kicks it into high gear to revive flailing Alcon unit

Emily Wasserman

' business has been struggling for some time now, and the company's efforts to help its eye-care business get back on track don't seem to be doing much to stanch the bleeding. So is kicking things crisis mode, planning to launch a game plan this year to its .

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS